Gene Therapy Oversight Efforts Should Be Expanded To Other Areas - HHS IG
Executive Summary
FDA and NIH should expand improvement efforts in gene therapy trial oversight to other types of clinical trials, the HHS Inspector General suggested in an update on recommendations for protecting human research subjects.
You may also be interested in...
Conflict Of Interest In Clinical Trials Target Of Increased FDA Inspections
FDA will increase its monitoring inspections of clinical trials where conflicts of interest exist.
Conflict Of Interest In Clinical Trials Target Of Increased FDA Inspections
FDA will increase its monitoring inspections of clinical trials where conflicts of interest exist.
FDA Clinical Site Inspections Should Look At Recruitment Tactics - IG Report
FDA clinical site inspections should focus on recruitment tactics as well as data integrity, the HHS Office of the Inspector General suggests in a report on clinical trial recruitment released June 12.